What is the main business of Pharmaselect Polska?

The main business activity of Pharmaselect Polska focuses on advertising agencies.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on November 24, 2010.

Where is the headquarters located?

The headquarters is located at: Sienkiewicza 22, 60-818 Poznań.

Who is on the management board?

The management board consists of: Karol Nowaczyk (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 400,000 (approx. $108,050).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

How much revenue was generated?

The company reported a revenue of $942,541 in 2024, which is a decrease of 21.6% compared to 2023.

Is the company profitable?

No, in 2024 the company was not profitable, reporting a net loss of $154,639.

Which cost dominates operating expenses?

The largest operating cost category falls under external services. This category amounted to $409,776 in 2024, representing 38% of all operating expenses.

Pharmaselect Polskasp. z o.o.

Advertising agencies

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2010-11-24

Share capital

400,000.00 PLN

Activity description

Pharmaselect Polska operates in the pharmaceutical sector, with a portfolio of medicines for rheumatic conditions, eye diseases and intensive care. Some products contain ingredients of natural origin, and the company emphasizes treatment efficacy and prevention.

Registered address

Sienkiewicza 22/209, 60-818 Poznań, Poland

Website

pharmaselect.pl

Phone

Electronic delivery address

AE:PL-21086-20100-RGHTA-15

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 43 days early.

2025filed
202423/06/2025
202313/06/2024
202227/06/2023
202120/06/2022
202021/06/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 1.52mMedianUSD 115.83kAverageUSD 1.11m

Net profit

This companyUSD 28.74kMedianUSD 4.00kAverageUSD 74.68k

Operating costs

This companyUSD 1.48mMedianUSD 100.69kAverageUSD 1.01m

Assets

This companyUSD 375.61kMedianUSD 57.32kAverageUSD 667.63k

Industry

Offer

Prescription medicines
Dietary supplements

Website technology

Website

WordPress

Authorized Representatives

Karol Nowaczyk – President of the Management Board

Manner of representation

In the event of the appointment of a multi-member management board, the joint action of two members of the management board, or of one member of the management board jointly with a commercial proxy, is required to submit a declaration of will and sign on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Andreas Bogg	100	$27,012.43	25%
Pharmaselect International Beteligungs Gmbh	300	$81,037.28	75%

Beneficial owners

Person	Rights

Subsidiaries

	Name	Share value	Stake
	Sklep-Pharmaselectsp. z o.o.	13,506.21 USD	100%

Bank accounts

Registered as a VAT taxpayer on 2010-12-23.

mBank
05 1140 1124 0000 4443 7900 1001

Debt

No entries in the National Debtors Register (KRZ).

Public aid

40 public aid cases recorded, with a total value of $37,627.

Grant date	Purpose	Gross amount	Granting body
Jul 9, 2026	Aid in the form of wage subsidies for employing workers with disabilities	$419$419	Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych
Jun 11, 2026	Aid in the form of wage subsidies for employing workers with disabilities	$419$419	Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych
May 12, 2026	Aid in the form of wage subsidies for employing workers with disabilities	$419$419	Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych

Competitors

	Name	Revenue	Website
	Anuncio Pharmasp. z o.o.	$710,156.11	anuncio-pharma.pl
	Pharmawaysp. z o.o.	$461,308.90	pharmaway.pl

Change history

Date	Event
2025-04-30	Switch to PKD 2025 (9 PKD 2007 codes → 9 PKD 2025 codes)
2015-10-20	PKD change (Removed: 14 codes)
2011-01-27	Address change (Turniowa 19 A, 60-116, Poznań → Sienkiewicza 22/209, 60-818, Poznań)
2010-11-24	Entered in the register

FAQ

Last updated: 2026-04-19